Best TWAS P=9.52e-17 · Best GWAS P=7.76e-16 conditioned to 0.0125
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | ROM1 | 0.25 | 0.17 | lasso | 3 | 0.18 | 1.5e-14 | -7.4 | 7.6 | 2.5e-14 | -0.78 | 0.48 | 0.52 | FALSE |
2 | GTEx | Adipose Visceral Omentum | ROM1 | 0.29 | 0.16 | lasso | 8 | 0.23 | 3.7e-12 | -7.0 | 8.0 | 1.4e-15 | -0.81 | 0.21 | 0.79 | FALSE |
3 | GTEx | Artery Aorta | ROM1 | 0.18 | 0.17 | lasso | 7 | 0.16 | 3.3e-09 | -6.8 | 6.9 | 4.5e-12 | -0.71 | 0.68 | 0.32 | FALSE |
4 | GTEx | Artery Tibial | ROM1 | 0.14 | 0.05 | lasso | 6 | 0.03 | 2.5e-03 | -6.9 | 7.0 | 2.6e-12 | -0.74 | 0.24 | 0.63 | FALSE |
5 | GTEx | Breast Mammary Tissue | ROM1 | 0.10 | 0.09 | lasso | 5 | 0.06 | 5.4e-04 | -6.8 | 7.0 | 2.6e-12 | -0.72 | 0.38 | 0.53 | FALSE |
6 | GTEx | Breast Mammary Tissue (Male) | ROM1 | 0.17 | 0.00 | enet | 18 | 0.01 | 2.2e-01 | -6.9 | 5.8 | 8.2e-09 | -0.55 | 0.04 | 0.24 | FALSE |
7 | GTEx | Breast Mammary Tissue (Female) | ROM1 | 0.16 | 0.02 | lasso | 4 | 0.04 | 2.9e-02 | -7.0 | 7.0 | 2.6e-12 | -0.69 | 0.08 | 0.42 | FALSE |
8 | GTEx | Cells EBV-transformed lymphocytes | EML3 | 0.33 | 0.22 | lasso | 8 | 0.21 | 1.6e-07 | -6.9 | -6.5 | 6.3e-11 | 0.65 | 0.67 | 0.28 | FALSE |
9 | GTEx | Cells Transformed fibroblasts | MTA2 | 0.06 | 0.09 | lasso | 1 | 0.07 | 3.0e-06 | -7.3 | -7.3 | 2.3e-13 | 0.82 | 0.43 | 0.51 | FALSE |
10 | GTEx | Cells Transformed fibroblasts | EML3 | 0.19 | 0.16 | lasso | 9 | 0.18 | 7.3e-14 | -7.3 | -7.5 | 6.2e-14 | 0.81 | 0.65 | 0.35 | FALSE |
11 | GTEx | Cells Transformed fibroblasts | HNRNPUL2 | 0.11 | 0.04 | enet | 14 | 0.05 | 9.8e-05 | -3.2 | 6.0 | 2.1e-09 | -0.84 | 0.03 | 0.97 | FALSE |
12 | GTEx | Esophagus Mucosa | MTA2 | 0.29 | 0.34 | lasso | 5 | 0.33 | 6.9e-23 | -6.9 | -7.0 | 3.1e-12 | 0.71 | 0.95 | 0.05 | FALSE |
13 | GTEx | Esophagus Mucosa | EML3 | 0.40 | 0.43 | lasso | 8 | 0.46 | 1.8e-33 | -6.8 | -7.1 | 1.3e-12 | 0.72 | 0.95 | 0.05 | FALSE |
14 | GTEx | Lung | ROM1 | 0.25 | 0.18 | enet | 13 | 0.20 | 2.2e-15 | -6.9 | 7.6 | 3.3e-14 | -0.78 | 0.87 | 0.13 | FALSE |
15 | GTEx | Lung | EML3 | 0.07 | 0.04 | lasso | 3 | 0.01 | 2.5e-02 | -6.9 | -6.9 | 5.0e-12 | 0.71 | 0.24 | 0.39 | FALSE |
16 | GTEx | Nerve Tibial | ROM1 | 0.15 | 0.06 | lasso | 7 | 0.06 | 2.9e-05 | -7.4 | 5.9 | 3.2e-09 | -0.64 | 0.10 | 0.88 | FALSE |
17 | GTEx | Nerve Tibial | EML3 | 0.17 | 0.10 | lasso | 4 | 0.09 | 3.9e-07 | -6.9 | -7.5 | 4.9e-14 | 0.77 | 0.14 | 0.86 | FALSE |
18 | GTEx | Nerve Tibial | B3GAT3 | 0.18 | 0.11 | lasso | 3 | 0.09 | 4.7e-07 | -8.0 | -7.9 | 2.0e-15 | 0.97 | 0.00 | 1.00 | FALSE |
19 | GTEx | Ovary | ROM1 | 0.25 | 0.00 | lasso | 5 | 0.00 | 3.3e-01 | -7.3 | 7.8 | 6.4e-15 | -0.81 | 0.07 | 0.28 | FALSE |
20 | GTEx | Pituitary | STX5 | 0.22 | 0.11 | lasso | 3 | 0.11 | 9.7e-04 | -2.5 | 6.5 | 6.5e-11 | -0.55 | 0.05 | 0.44 | FALSE |
21 | GTEx | Skin Not Sun Exposed Suprapubic | ROM1 | 0.15 | 0.08 | lasso | 1 | 0.06 | 2.8e-04 | -8.1 | 8.1 | 7.8e-16 | -1.00 | 0.01 | 0.96 | FALSE |
22 | GTEx | Skin Not Sun Exposed Suprapubic | EML3 | 0.20 | 0.19 | lasso | 3 | 0.24 | 2.7e-13 | -6.9 | -7.6 | 3.7e-14 | 0.78 | 0.14 | 0.86 | FALSE |
23 | GTEx | Skin Not Sun Exposed Suprapubic | B3GAT3 | 0.18 | 0.11 | lasso | 3 | 0.11 | 9.8e-07 | -8.0 | -8.1 | 4.1e-16 | 0.96 | 0.00 | 1.00 | FALSE |
24 | GTEx | Skin Sun Exposed Lower leg | MTA2 | 0.14 | 0.04 | enet | 21 | 0.05 | 3.1e-05 | -7.4 | -5.9 | 3.2e-09 | 0.73 | 0.08 | 0.89 | FALSE |
25 | GTEx | Skin Sun Exposed Lower leg | ROM1 | 0.13 | 0.11 | lasso | 4 | 0.10 | 9.7e-09 | -6.9 | 6.7 | 1.6e-11 | -0.70 | 0.63 | 0.37 | FALSE |
26 | GTEx | Skin Sun Exposed Lower leg | EML3 | 0.32 | 0.25 | enet | 19 | 0.26 | 8.0e-22 | -6.9 | -7.7 | 1.4e-14 | 0.71 | 0.92 | 0.08 | FALSE |
27 | GTEx | Spleen | GANAB | 0.35 | -0.01 | lasso | 9 | 0.01 | 1.3e-01 | -6.9 | -6.4 | 1.4e-10 | 0.71 | 0.05 | 0.42 | FALSE |
28 | GTEx | Spleen | MTA2 | 0.26 | 0.07 | enet | 19 | 0.07 | 8.7e-03 | -7.0 | -6.5 | 9.5e-11 | 0.68 | 0.05 | 0.76 | FALSE |
29 | GTEx | Stomach | EML3 | 0.11 | 0.04 | enet | 5 | 0.03 | 2.1e-02 | -7.3 | -7.3 | 2.8e-13 | 0.79 | 0.08 | 0.44 | FALSE |
30 | GTEx | Testis | EML3 | 0.27 | 0.22 | enet | 15 | 0.29 | 2.7e-13 | -6.9 | -7.5 | 6.6e-14 | 0.82 | 0.38 | 0.62 | FALSE |
31 | GTEx | Thyroid | ROM1 | 0.17 | 0.16 | lasso | 8 | 0.16 | 3.6e-12 | -6.9 | 7.2 | 7.8e-13 | -0.72 | 0.72 | 0.28 | FALSE |
32 | GTEx | Thyroid | EML3 | 0.10 | 0.11 | lasso | 4 | 0.10 | 5.9e-08 | -6.9 | -6.9 | 6.8e-12 | 0.70 | 0.36 | 0.63 | FALSE |
33 | GTEx | Thyroid | B3GAT3 | 0.18 | 0.09 | lasso | 5 | 0.12 | 1.4e-09 | -8.0 | -7.9 | 2.1e-15 | 0.90 | 0.00 | 1.00 | FALSE |
34 | GTEx | Whole Blood | EML3 | 0.17 | 0.09 | lasso | 7 | 0.08 | 6.3e-08 | -6.8 | -7.1 | 1.7e-12 | 0.74 | 0.78 | 0.22 | FALSE |
35 | METSIM | Adipose | B3GAT3 | 0.08 | 0.06 | enet | 16 | 0.07 | 5.4e-11 | -7.7 | -7.4 | 2.0e-13 | 0.82 | 0.02 | 0.98 | FALSE |
36 | METSIM | Adipose | EEF1G | 0.08 | 0.05 | bslmm | 375 | 0.06 | 4.5e-09 | -7.4 | 6.4 | 1.6e-10 | -0.66 | 0.61 | 0.39 | FALSE |
37 | METSIM | Adipose | EML3 | 0.15 | 0.14 | bslmm | 376 | 0.14 | 1.9e-20 | -6.8 | -6.5 | 6.9e-11 | 0.68 | 0.94 | 0.06 | FALSE |
38 | METSIM | Adipose | ROM1 | 0.05 | 0.02 | enet | 17 | 0.02 | 9.9e-05 | -6.9 | 6.2 | 4.9e-10 | -0.57 | 0.48 | 0.48 | FALSE |
39 | METSIM | Adipose | TTC9C | 0.07 | 0.07 | enet | 25 | 0.08 | 1.4e-12 | -3.3 | -5.3 | 1.2e-07 | 0.71 | 0.73 | 0.27 | FALSE |
40 | YFS | Blood | EEF1G | 0.30 | 0.45 | lasso | 6 | 0.45 | 3.6e-166 | -6.8 | 6.8 | 7.7e-12 | -0.71 | 0.97 | 0.03 | FALSE |
41 | YFS | Blood | EML3 | 0.20 | 0.31 | lasso | 12 | 0.33 | 1.3e-110 | -7.4 | -7.5 | 7.9e-14 | 0.76 | 0.61 | 0.39 | FALSE |
42 | YFS | Blood | INTS5 | 0.09 | 0.12 | lasso | 4 | 0.12 | 1.9e-38 | -8.0 | -8.3 | 1.3e-16 | 0.97 | 0.00 | 1.00 | FALSE |
43 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | EEF1G | 0.04 | 0.05 | lasso | 1 | 0.04 | 1.1e-04 | -7.4 | 7.4 | 1.3e-13 | -0.73 | 0.05 | 0.90 | FALSE |
44 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C11orf83 | 0.01 | 0.00 | blup | 23 | 0.01 | 4.2e-03 | -7.7 | 6.9 | 6.3e-12 | -0.86 | 0.01 | 0.62 | FALSE |
45 | The Cancer Genome Atlas | Breast Invasive Carcinoma | EEF1G | 0.02 | 0.04 | lasso | 2 | 0.03 | 6.3e-07 | -6.8 | 6.9 | 6.8e-12 | -0.71 | 0.24 | 0.76 | FALSE |
46 | The Cancer Genome Atlas | Breast Invasive Carcinoma | EML3 | 0.02 | 0.02 | lasso | 4 | 0.02 | 2.5e-05 | -7.4 | -7.3 | 2.0e-13 | 0.73 | 0.28 | 0.70 | FALSE |
47 | The Cancer Genome Atlas | Breast Invasive Carcinoma | ROM1 | 0.01 | 0.02 | enet | 4 | 0.02 | 2.4e-04 | -7.4 | 7.6 | 3.2e-14 | -0.74 | 0.09 | 0.75 | FALSE |
48 | The Cancer Genome Atlas | Colon Adenocarcinoma | EEF1G | 0.07 | 0.11 | lasso | 1 | 0.11 | 9.2e-07 | -6.9 | 6.9 | 5.2e-12 | -0.69 | 0.11 | 0.89 | FALSE |
49 | The Cancer Genome Atlas | Colon Adenocarcinoma | EML3 | 0.07 | 0.03 | blup | 29 | 0.05 | 6.5e-04 | -7.3 | -6.7 | 2.8e-11 | 0.69 | 0.10 | 0.33 | FALSE |
50 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | EEF1G | 0.10 | 0.09 | blup | 26 | 0.09 | 9.8e-11 | -6.9 | 6.1 | 9.6e-10 | -0.61 | 0.30 | 0.70 | FALSE |
51 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | EML3 | 0.06 | 0.05 | blup | 27 | 0.06 | 7.6e-07 | -7.7 | -7.2 | 8.3e-13 | 0.77 | 0.03 | 0.97 | FALSE |
52 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | ROM1 | 0.04 | 0.02 | blup | 22 | 0.02 | 6.2e-03 | -7.3 | 6.1 | 1.1e-09 | -0.68 | 0.04 | 0.28 | FALSE |
53 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | EEF1G | 0.11 | 0.12 | blup | 27 | 0.13 | 5.5e-14 | -6.9 | 7.2 | 7.9e-13 | -0.73 | 0.31 | 0.69 | FALSE |
54 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | EML3 | 0.04 | 0.06 | lasso | 3 | 0.06 | 1.7e-07 | -6.9 | -6.9 | 5.9e-12 | 0.70 | 0.60 | 0.40 | FALSE |
55 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | EEF1G | 0.07 | 0.04 | blup | 28 | 0.07 | 9.8e-05 | -7.3 | 7.3 | 2.8e-13 | -0.74 | 0.05 | 0.80 | FALSE |
56 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | EML3 | 0.06 | 0.09 | lasso | 2 | 0.08 | 1.6e-05 | -7.7 | -7.8 | 8.9e-15 | 0.79 | 0.02 | 0.97 | FALSE |
57 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C11orf83 | 0.02 | 0.01 | blup | 24 | 0.01 | 1.5e-02 | -7.7 | 7.4 | 1.2e-13 | -0.86 | 0.01 | 0.84 | FALSE |
58 | The Cancer Genome Atlas | Brain Lower Grade Glioma | EEF1G | 0.06 | 0.07 | blup | 27 | 0.07 | 8.1e-09 | -6.8 | 6.8 | 1.0e-11 | -0.75 | 0.04 | 0.96 | FALSE |
59 | The Cancer Genome Atlas | Brain Lower Grade Glioma | EML3 | 0.03 | 0.04 | blup | 28 | 0.03 | 7.6e-05 | -7.4 | -7.1 | 1.0e-12 | 0.74 | 0.18 | 0.78 | FALSE |
60 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | EEF1G | 0.06 | 0.03 | blup | 27 | 0.04 | 4.5e-03 | -7.7 | 7.7 | 1.0e-14 | -0.78 | 0.01 | 0.79 | FALSE |
61 | The Cancer Genome Atlas | Lung Adenocarcinoma | EEF1G | 0.06 | 0.08 | lasso | 8 | 0.08 | 5.9e-10 | -6.8 | 7.3 | 3.4e-13 | -0.78 | 0.11 | 0.89 | FALSE |
62 | The Cancer Genome Atlas | Lung Adenocarcinoma | EML3 | 0.03 | 0.03 | blup | 28 | 0.03 | 8.4e-05 | -6.8 | -7.7 | 1.8e-14 | 0.76 | 0.29 | 0.69 | FALSE |
63 | The Cancer Genome Atlas | Lung Adenocarcinoma | ROM1 | 0.04 | 0.04 | blup | 23 | 0.04 | 9.5e-06 | -6.8 | 7.4 | 1.6e-13 | -0.80 | 0.23 | 0.76 | FALSE |
64 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C11orf83 | 0.07 | 0.01 | blup | 24 | 0.01 | 1.0e-02 | -8.0 | 7.5 | 6.1e-14 | -0.80 | 0.00 | 0.90 | FALSE |
65 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | EEF1G | 0.08 | 0.13 | lasso | 4 | 0.12 | 3.1e-13 | -6.8 | 6.8 | 7.5e-12 | -0.71 | 0.35 | 0.65 | FALSE |
66 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | EML3 | 0.04 | 0.05 | blup | 27 | 0.05 | 3.5e-06 | -7.4 | -6.7 | 2.0e-11 | 0.75 | 0.10 | 0.89 | FALSE |
67 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | EML3 | 0.03 | 0.02 | blup | 27 | 0.03 | 3.5e-03 | -7.4 | -7.8 | 7.4e-15 | 0.81 | 0.02 | 0.73 | FALSE |
68 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | EEF1G | 0.08 | 0.08 | blup | 27 | 0.05 | 3.6e-03 | -6.8 | 6.6 | 5.1e-11 | -0.68 | 0.10 | 0.63 | FALSE |
69 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | EEF1G | 0.08 | 0.00 | blup | 27 | 0.04 | 1.3e-02 | -6.8 | 6.5 | 6.7e-11 | -0.68 | 0.03 | 0.65 | FALSE |
70 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C11orf83 | 0.03 | 0.03 | blup | 24 | 0.02 | 5.5e-03 | -8.0 | 7.4 | 1.8e-13 | -0.94 | 0.00 | 0.99 | FALSE |
71 | The Cancer Genome Atlas | Prostate Adenocarcinoma | EEF1G | 0.08 | 0.13 | lasso | 2 | 0.12 | 1.8e-12 | -6.8 | 6.8 | 7.4e-12 | -0.71 | 0.35 | 0.65 | FALSE |
72 | The Cancer Genome Atlas | Prostate Adenocarcinoma | EML3 | 0.09 | 0.14 | lasso | 1 | 0.14 | 3.4e-14 | -7.4 | -7.4 | 1.3e-13 | 0.73 | 0.16 | 0.84 | FALSE |
73 | The Cancer Genome Atlas | Rectum Adenocarcinoma | EML3 | 0.36 | 0.08 | blup | 27 | 0.19 | 3.7e-05 | -7.4 | -5.4 | 6.7e-08 | 0.55 | 0.05 | 0.31 | FALSE |
74 | The Cancer Genome Atlas | Soft Tissue Sarcoma | ROM1 | 0.06 | 0.05 | blup | 24 | 0.03 | 8.1e-03 | -6.8 | 7.3 | 2.1e-13 | -0.73 | 0.06 | 0.27 | FALSE |
75 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | EML3 | 0.32 | 0.03 | lasso | 2 | 0.07 | 4.9e-03 | -7.3 | -5.4 | 8.0e-08 | 0.77 | 0.02 | 0.36 | FALSE |
76 | The Cancer Genome Atlas | Stomach Adenocarcinoma | EEF1G | 0.05 | 0.07 | blup | 27 | 0.07 | 1.7e-05 | -6.9 | 6.9 | 4.4e-12 | -0.72 | 0.11 | 0.89 | FALSE |
77 | The Cancer Genome Atlas | Stomach Adenocarcinoma | ROM1 | 0.05 | 0.08 | lasso | 3 | 0.08 | 3.1e-06 | -6.9 | 7.1 | 1.1e-12 | -0.74 | 0.23 | 0.75 | FALSE |
78 | The Cancer Genome Atlas | Thyroid Carcinoma | EEF1G | 0.15 | 0.27 | blup | 27 | 0.28 | 3.6e-27 | -6.9 | 6.2 | 7.1e-10 | -0.66 | 0.28 | 0.72 | FALSE |
79 | The Cancer Genome Atlas | Thyroid Carcinoma | EML3 | 0.11 | 0.10 | blup | 28 | 0.12 | 2.3e-11 | -7.4 | -8.3 | 9.5e-17 | 0.78 | 0.03 | 0.97 | TRUE |
80 | The Cancer Genome Atlas | Thyroid Carcinoma | ROM1 | 0.03 | 0.02 | blup | 23 | 0.02 | 1.1e-02 | -6.9 | 7.3 | 3.4e-13 | -0.77 | 0.05 | 0.62 | FALSE |